Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue.

Roth GA, Spada V, Hamill K, Bornstein MB.

Brain Res Dev Brain Res. 1995 Aug 28;88(1):102-8.

PMID:
7493400
2.

CSF-1 expression is upregulated in astrocyte cultures by IL-1 and TNF and affects microglial proliferation and morphology in organotypic cultures.

Shafit-Zagardo B, Sharma N, Berman JW, Bornstein MB, Brosnan CF.

Int J Dev Neurosci. 1993 Apr;11(2):189-98.

PMID:
8328300
3.

Hopeful prospects in multiple sclerosis.

Bornstein MB.

Hosp Pract (Off Ed). 1992 May 15;27(5):135-8, 141-2, 145-8 passim. No abstract available.

PMID:
1577883
4.

A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis.

Bornstein MB, Miller A, Slagle S, Weitzman M, Drexler E, Keilson M, Spada V, Weiss W, Appel S, Rolak L, et al.

Neurology. 1991 Apr;41(4):533-9.

PMID:
2011253
5.

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.

Lyman WD, Sonett JR, Brosnan CF, Elkin R, Bornstein MB.

J Neuroimmunol. 1989 Jun;23(1):73-81.

PMID:
2542370
6.

In memoriam Margaret Ransone Murray, (November 16, 1901-July 13, 1986).

Bornstein MB.

J Neuropathol Exp Neurol. 1989 Jan;48(1):111-2. No abstract available.

PMID:
2642299
7.

Electrophysiological analysis of factors involved in the primary demyelinating diseases: the rabbit eye model system.

Arezzo JC, Brosnan CF, Schroeder CE, Litwak MS, Bornstein MB.

Brain Res. 1988 Oct 18;462(2):286-300.

PMID:
3191390
8.

Clinical trial design in multiple sclerosis therapy.

Weiss W, Bornstein MB, Miller A, Slagle S.

Neurology. 1988 Jul;38(7 Suppl 2):80-1. No abstract available.

PMID:
3386846
9.

Clinical experience with COP-1 in multiple sclerosis.

Bornstein MB, Miller A, Slagle S, Weitzman M, Crystal H, Drexler E, Keilson M, Merriam A, Wassertheil-Smoller S, Spada V, et al.

Neurology. 1988 Jul;38(7 Suppl 2):66-9.

PMID:
3290717
10.

EAE serum decreases CNPase activity in cultures of B104 cells.

Elkin R, Lyman WD, Brosnan CF, Bornstein MB.

Ann N Y Acad Sci. 1988;540:396-7. No abstract available.

PMID:
2462816
11.

Quantitation of antigen-specific T-cell-induced demyelination in vitro.

Lyman WD, Roth GA, Brosnan CF, Bornstein MB, Raine CS.

J Neuroimmunol. 1988 Jan;17(2):175-80.

PMID:
2447126
12.

A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.

Bornstein MB, Miller A, Slagle S, Weitzman M, Crystal H, Drexler E, Keilson M, Merriam A, Wassertheil-Smoller S, Spada V, et al.

N Engl J Med. 1987 Aug 13;317(7):408-14.

PMID:
3302705
13.

Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line.

Sheppard RD, Raine CS, Bornstein MB, Udem SA.

Proc Natl Acad Sci U S A. 1986 Oct;83(20):7913-7.

14.

Antigen-specific T cells can mediate demyelination in organotypic central nervous system cultures.

Lyman WD, Roth GA, Chiu FC, Brosnan CF, Bornstein MB, Raine CS.

Cell Immunol. 1986 Oct 1;102(1):217-26.

PMID:
2433050
15.

Sustained hyperexcitability elicited by repetitive electric stimulation of organotypic hippocampal explants.

Fowler J, Bornstein MB, Crain SM.

Brain Res. 1986 Jul 23;378(2):398-404.

PMID:
3730883
16.

Effect of antiglycolipid antisera on the lipid composition of cultured mouse spinal cords.

Saito M, Macala LJ, Roth GA, Bornstein MB, Yu RK.

Exp Neurol. 1986 Jun;92(3):752-6.

PMID:
3709746
17.

Chemical neurotoxicity: detection and analysis in organotypic cultures of sensory and motor systems.

Spencer PS, Crain SM, Bornstein MB, Peterson ER, Van de Water T.

Food Chem Toxicol. 1986 Jun-Jul;24(6-7):539-44. Review.

PMID:
3536691
18.

Transformation of cells of astrocyte lineage into macrophage-like cells in organotypic cultures of mouse spinal cord tissue.

Kusaka H, Hirano A, Bornstein MB, Moore GR, Raine CS.

J Neurol Sci. 1986 Jan;72(1):77-89.

PMID:
2419515
19.
20.

Immunogenic potentials of copolymer I in normal human lymphocytes.

Brosnan CF, Litwak M, Neighbour PA, Lyman WD, Carter TH, Bornstein MB, Bloom BR.

Neurology. 1985 Dec;35(12):1754-9.

PMID:
2415875
21.

Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures.

Roth GA, Röyttä M, Yu RK, Raine CS, Bornstein MB.

Brain Res. 1985 Jul 22;339(1):9-18.

PMID:
4027618
22.

Fine structure of astrocytic processes during serum-induced demyelination in vitro.

Kusaka H, Hirano A, Bornstein MB, Raine CS.

J Neurol Sci. 1985 Jul;69(3):255-67.

PMID:
4031946
23.

Measles virus matrix protein synthesized in a subacute sclerosing panencephalitis cell line.

Sheppard RD, Raine CS, Bornstein MB, Udem SA.

Science. 1985 Jun 7;228(4704):1219-21.

PMID:
4001938
24.

Basal lamina formation by astrocytes in organotypic cultures of mouse spinal cord tissue.

Kusaka H, Hirano A, Bornstein MB, Raine CS.

J Neuropathol Exp Neurol. 1985 May;44(3):295-303.

PMID:
3989584
25.

Preliminary analysis of cell and serum-induced demyelination in vitro using a syngeneic system.

Röyttä M, Lyman WD, Roth GA, Bornstein MB, Raine CS.

Acta Neurol Scand. 1985 Mar;71(3):226-36.

PMID:
3993329
26.

Correlation between 2',3'-cyclic nucleotide 3'-phosphohydrolase activity and demyelination in vitro using a syngeneic system.

Roth GA, Bornstein MB, Röyttä M, Lyman WD, Raine CS.

J Neurochem. 1985 Feb;44(2):654-7.

PMID:
2981290
27.

The organization of astrocytes in organotypic mouse spinal cord culture: an electron microscope study.

Kusaka H, Hirano A, Bornstein MB, Raine CS.

Neuropathol Appl Neurobiol. 1984 Nov-Dec;10(6):411-22.

PMID:
6527730
28.

The evolution of cellular degeneration in dorsal root ganglia exposed to doxorubicin in tissue culture.

Zagoren JC, Seelig M, Bornstein MB, Spencer PS.

J Neuropathol Exp Neurol. 1984 Jul;43(4):384-94.

PMID:
6737008
29.

Quantitative chemical analysis of demyelination in cultured mouse spinal cord.

Roth GA, Bornstein MB.

Brain Res. 1984 Jul;317(1):105-11.

PMID:
6087997
30.

Copolymer I: effect on normal human lymphocytes.

Brosnan CF, Litwak M, Neighbour PA, Bornstein MB.

Ann N Y Acad Sci. 1984;436:498-9. No abstract available.

PMID:
6598027
31.

Clinical trials of copolymer I in multiple sclerosis.

Bornstein MB, Miller AI, Slagle S, Arnon R, Sela M, Teitelbaum D.

Ann N Y Acad Sci. 1984;436:366-72. No abstract available.

PMID:
6398019
32.
33.

Ultrastructural studies of the dying-back process. VI. Examination of nerve fibers undergoing giant axonal degeneration in organotypic culture.

Veronesi B, Peterson ER, Bornstein MB, Spencer PS.

J Neuropathol Exp Neurol. 1983 Mar;42(2):153-65.

PMID:
6827287
34.

The twitcher mouse: myelinogenesis in organotypic culture.

Bourque EA, Bornstein MB, Peterson ER, Suzuki K.

Brain Res. 1983 Feb 21;261(2):295-301.

PMID:
6403202
35.

Myelination in organotypic cultures of sympathetic ganglia.

Heath JW, Peterson ER, Bornstein MB, Raine CS.

Brain Res. 1982 Oct;281(2):238-41.

PMID:
7139353
36.

Multiple sclerosis: trial of a synthetic polypeptide.

Bornstein MB, Miller AI, Teitelbaum D, Arnon R, Sela M.

Ann Neurol. 1982 Mar;11(3):317-9.

PMID:
7092185
37.

Buckthorn neuropathy in vitro : evidence for a primary neuronal effect.

Heath JW, Ueda S, Bornstein MB, Daves GD Jr, Raine CS.

J Neuropathol Exp Neurol. 1982 Mar;41(2):204-20.

PMID:
6278099
38.

Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target.

Raine CS, Johnson AB, Marcus DM, Suzuki A, Bornstein MB.

J Neurol Sci. 1981 Oct;52(1):117-31.

PMID:
6170737
39.

Catecholamine-containing neurons in cultures of fetal rat hypothalamus: distribution, morphology, and maturation.

Feldman SC, Brown LL, Bornstein MB.

Cell Mol Neurobiol. 1981 Sep;1(3):279-88.

PMID:
7346172
40.
41.

Augmentation of immune-mediated demyelination by lipid haptens.

Raine CS, Traugott U, Farooq M, Bornstein MB, Norton WT.

Lab Invest. 1981 Aug;45(2):174-82.

PMID:
6167795
42.
43.

Experimental allergic encephalomyelitis. Characterization of serum factors causing demyelination and swelling of myelin.

Grundke-Iqbal I, Raine CS, Johnson AB, Brosnan CF, Bornstein MB.

J Neurol Sci. 1981 Apr;50(1):63-79.

PMID:
7229659
44.

The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis.

Brosnan CF, Bornstein MB, Bloom BR.

J Immunol. 1981 Feb;126(2):614-20. No abstract available.

PMID:
6256443
45.

Development of ganglion cells and their axons in organized cultures of fetal mouse retinal explants.

Smalheiser NR, Crain SM, Bornstein MB.

Brain Res. 1981 Jan 5;204(1):159-78.

PMID:
6166351
46.

Plasmapheresis in multiple sclerosis: preliminary findings.

Dau PC, Petajan JH, Johnson KP, Panitch HS, Bornstein MB.

Neurology. 1980 Oct;30(10):1023-8.

PMID:
6448360
47.

A sensitive fluorometric assay for 2',3'-cyclic nucleotide 3'-phosphohydrolase.

Weissbarth S, Maker HS, Lehrer GM, Schneider S, Bornstein MB.

J Neurochem. 1980 Aug;35(2):503-5. No abstract available.

PMID:
6256488
48.

Multiple sclerosis: serum gamma globulin and demyelination in organ culture.

Grundke-Iqbal I, Bornstein MB.

Neurology. 1980 Jul;30(7 Pt 1):749-54.

PMID:
6156428
49.

Further ultrastructural observations of virus morphogenesis and myelin pathology in JHM virus encephalomyelitis.

Fleury HJ, Sheppard RD, Bornstein MB, Raine CS.

Neuropathol Appl Neurobiol. 1980 May-Jun;6(3):165-79.

PMID:
6250094
50.

Treatment of multiple sclerosis with a synthetic polypeptide: preliminary results.

Bornstein MB, Miller AE, Teitelbaum D, Arnon R, Sela M.

Trans Am Neurol Assoc. 1980;105:348-50. No abstract available.

PMID:
6758285

Supplemental Content

Loading ...
Support Center